Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Lisa Abuogi

Concepts (182)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
59
2026
3215
8.960
Why?
Anti-HIV Agents
27
2026
914
7.030
Why?
Infectious Disease Transmission, Vertical
24
2026
188
6.160
Why?
Kenya
37
2026
129
4.330
Why?
Pregnancy Complications, Infectious
15
2026
438
3.270
Why?
Anti-Retroviral Agents
10
2026
250
2.810
Why?
Viral Load
14
2026
526
2.640
Why?
Breast Feeding
10
2026
447
2.330
Why?
Sexual Partners
9
2026
195
1.860
Why?
Sustained Virologic Response
2
2026
48
1.480
Why?
Pregnancy
31
2026
7230
1.410
Why?
Intimate Partner Violence
4
2025
93
1.350
Why?
Medication Adherence
7
2025
535
1.320
Why?
Qualitative Research
8
2026
1734
1.320
Why?
Text Messaging
4
2023
188
1.310
Why?
Infant
29
2026
10114
1.180
Why?
Social Stigma
10
2026
174
1.130
Why?
HIV-1
4
2026
913
1.100
Why?
Focus Groups
6
2026
588
1.090
Why?
Mothers
7
2022
772
1.080
Why?
Drug Monitoring
2
2024
399
1.070
Why?
Peripartum Period
2
2024
19
1.010
Why?
Social Support
5
2024
646
0.990
Why?
Transition to Adult Care
2
2026
111
0.950
Why?
Female
58
2026
79499
0.900
Why?
Pre-Exposure Prophylaxis
2
2025
272
0.890
Why?
Spouses
4
2020
107
0.880
Why?
Prenatal Care
4
2020
310
0.880
Why?
Young Adult
22
2026
14330
0.780
Why?
Fathers
1
2023
53
0.760
Why?
Postpartum Period
8
2025
377
0.760
Why?
Zambia
6
2026
61
0.760
Why?
Peer Group
2
2024
251
0.730
Why?
Humans
66
2026
146342
0.710
Why?
Fertilization
2
2026
44
0.710
Why?
Patient Navigation
1
2024
126
0.700
Why?
Drug Resistance, Viral
4
2026
127
0.670
Why?
Interviews as Topic
3
2024
930
0.650
Why?
Mentors
3
2021
217
0.610
Why?
Adolescent
23
2026
22557
0.600
Why?
Adult
32
2026
41087
0.600
Why?
Male
35
2026
73396
0.570
Why?
Infant, Newborn
11
2026
6460
0.550
Why?
Randomized Controlled Trials as Topic
6
2026
1763
0.540
Why?
Continuity of Patient Care
1
2020
298
0.540
Why?
Motivation
1
2022
605
0.520
Why?
Heterocyclic Compounds, 3-Ring
3
2026
44
0.520
Why?
Child
23
2026
22693
0.510
Why?
Health Facilities
2
2021
85
0.510
Why?
Health Facility Administration
1
2017
8
0.500
Why?
Telemedicine
2
2025
966
0.500
Why?
Community Health Services
2
2019
229
0.500
Why?
Spouse Abuse
1
2017
39
0.490
Why?
Truth Disclosure
1
2017
51
0.490
Why?
Reproductive Health Services
2
2026
23
0.480
Why?
Reminder Systems
1
2018
149
0.480
Why?
Patient Dropouts
1
2016
65
0.460
Why?
Patient Acceptance of Health Care
4
2026
881
0.450
Why?
HIV Integrase Inhibitors
2
2026
80
0.430
Why?
Health Resources
1
2016
131
0.430
Why?
Treatment Failure
4
2026
361
0.420
Why?
Tuberculosis
2
2014
290
0.390
Why?
Point-of-Care Systems
3
2023
185
0.370
Why?
Health Knowledge, Attitudes, Practice
5
2026
1408
0.360
Why?
Patient Compliance
1
2016
589
0.350
Why?
Prospective Studies
6
2025
8123
0.330
Why?
Multicenter Studies as Topic
2
2026
417
0.320
Why?
Students
2
2026
649
0.310
Why?
Colorado
4
2025
4595
0.310
Why?
Consultants
2
2026
12
0.290
Why?
Child, Preschool
10
2026
11913
0.290
Why?
Practice Guidelines as Topic
2
2024
1591
0.250
Why?
Trust
2
2026
160
0.250
Why?
Lactation
2
2026
193
0.250
Why?
Developing Countries
2
2021
312
0.240
Why?
Case-Control Studies
3
2018
3647
0.230
Why?
Viremia
1
2026
158
0.220
Why?
Sexual Behavior
2
2026
490
0.210
Why?
Cross-Sectional Studies
6
2026
5899
0.210
Why?
Retrospective Studies
8
2024
17438
0.200
Why?
United States
5
2026
16136
0.200
Why?
Intention
1
2025
187
0.200
Why?
Infant Health
1
2023
24
0.190
Why?
Risk Factors
5
2025
10921
0.190
Why?
Maternal Health
1
2023
50
0.190
Why?
RNA, Viral
2
2024
693
0.190
Why?
Dried Blood Spot Testing
1
2024
129
0.190
Why?
Prevalence
3
2024
2861
0.190
Why?
Fear
1
2026
373
0.190
Why?
Proportional Hazards Models
4
2024
1331
0.180
Why?
CD4 Lymphocyte Count
2
2024
280
0.180
Why?
DNA, Viral
1
2024
354
0.180
Why?
Telephone
1
2023
175
0.180
Why?
Drug Resistance
1
2022
145
0.170
Why?
Oxazines
3
2026
36
0.170
Why?
Feasibility Studies
1
2025
1135
0.160
Why?
Treatment Adherence and Compliance
1
2021
27
0.160
Why?
Emigrants and Immigrants
1
2023
160
0.160
Why?
Public Health Surveillance
1
2021
84
0.160
Why?
Treatment Outcome
5
2021
11821
0.160
Why?
Asymptomatic Infections
1
2020
40
0.160
Why?
Organophosphates
1
2022
179
0.160
Why?
Mass Screening
2
2020
1307
0.160
Why?
Reward
1
2022
242
0.150
Why?
Infant, Low Birth Weight
1
2021
154
0.150
Why?
Pilot Projects
1
2025
1888
0.150
Why?
Symptom Assessment
1
2021
138
0.150
Why?
Pyridones
3
2026
210
0.150
Why?
Patient Participation
1
2023
457
0.150
Why?
Acquired Immunodeficiency Syndrome
1
2021
238
0.150
Why?
Adenine
1
2022
339
0.150
Why?
Health Personnel
2
2023
754
0.150
Why?
Piperazines
3
2026
368
0.140
Why?
Disclosure
1
2019
91
0.140
Why?
C-Reactive Protein
1
2021
429
0.140
Why?
Hospitals
1
2023
738
0.140
Why?
Odds Ratio
1
2021
1077
0.140
Why?
Emotions
1
2023
559
0.130
Why?
Ambulatory Care
1
2023
628
0.130
Why?
Health Services Accessibility
1
2026
1107
0.130
Why?
Diagnostic Tests, Routine
1
2018
109
0.130
Why?
Self Disclosure
1
2017
62
0.130
Why?
Surveys and Questionnaires
4
2026
6073
0.130
Why?
Research Design
1
2023
1143
0.130
Why?
HIV
1
2018
249
0.130
Why?
Pregnancy Outcome
1
2021
503
0.130
Why?
Disease Management
1
2021
651
0.120
Why?
Decision Making
1
2024
993
0.120
Why?
HIV Seropositivity
1
2017
118
0.120
Why?
Comorbidity
1
2021
1665
0.120
Why?
Marriage
1
2017
122
0.110
Why?
Rural Population
2
2017
677
0.110
Why?
Logistic Models
2
2025
2126
0.110
Why?
Health Services Research
1
2017
390
0.100
Why?
Hospitalization
2
2023
2475
0.100
Why?
Attitude of Health Personnel
2
2024
1219
0.100
Why?
Isoniazid
1
2014
71
0.100
Why?
Biomarkers
2
2024
4340
0.100
Why?
Universities
2
2026
451
0.100
Why?
Severity of Illness Index
1
2021
2921
0.090
Why?
Cohort Studies
3
2024
6077
0.090
Why?
Family Characteristics
2
2026
203
0.090
Why?
Incidence
2
2022
2936
0.090
Why?
Antitubercular Agents
1
2014
212
0.090
Why?
Delivery of Health Care
1
2018
947
0.080
Why?
Nasopharynx
2
2022
72
0.080
Why?
Mutation
1
2022
4093
0.080
Why?
Depression
1
2020
1575
0.080
Why?
Prognosis
1
2018
4351
0.070
Why?
Time Factors
1
2018
7109
0.060
Why?
Africa South of the Sahara
1
2026
56
0.060
Why?
Lamivudine
1
2026
63
0.060
Why?
Risk Assessment
2
2025
3712
0.060
Why?
Canada
1
2026
432
0.050
Why?
Observation
1
2024
51
0.050
Why?
Cerebrospinal Fluid
1
2024
88
0.050
Why?
Interpersonal Relations
1
2026
387
0.050
Why?
ROC Curve
1
2025
617
0.050
Why?
Drug Therapy, Combination
1
2026
1036
0.050
Why?
North America
1
2023
300
0.050
Why?
Point-of-Care Testing
1
2022
36
0.050
Why?
Milk, Human
1
2023
176
0.040
Why?
Africa, Northern
1
2021
4
0.040
Why?
Adaptive Immunity
1
2022
173
0.040
Why?
Professional-Patient Relations
1
2022
146
0.040
Why?
Oropharynx
1
2020
46
0.040
Why?
Genotype
1
2025
1879
0.040
Why?
Income
1
2021
206
0.040
Why?
Principal Component Analysis
1
2020
192
0.040
Why?
Longitudinal Studies
1
2026
3017
0.030
Why?
Mental Health
1
2025
779
0.030
Why?
Cognitive Dysfunction
1
2024
481
0.030
Why?
House Calls
1
2019
154
0.030
Why?
Gene Expression
1
2022
1463
0.030
Why?
Delivery, Obstetric
1
2018
164
0.030
Why?
Poverty
1
2021
530
0.030
Why?
Middle Aged
3
2026
36619
0.030
Why?
Hospitals, Pediatric
1
2020
561
0.030
Why?
Pandemics
1
2023
1707
0.030
Why?
Program Evaluation
1
2017
952
0.020
Why?
Reproducibility of Results
1
2020
3416
0.020
Why?
Aged
1
2022
26432
0.010
Why?
Abuogi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)